CA1195977A - Quinazoline cardiac stimulants - Google Patents
Quinazoline cardiac stimulantsInfo
- Publication number
- CA1195977A CA1195977A CA000428080A CA428080A CA1195977A CA 1195977 A CA1195977 A CA 1195977A CA 000428080 A CA000428080 A CA 000428080A CA 428080 A CA428080 A CA 428080A CA 1195977 A CA1195977 A CA 1195977A
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- process according
- group
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8214206 | 1982-05-15 | ||
| GB8214206 | 1982-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1195977A true CA1195977A (en) | 1985-10-29 |
Family
ID=10530384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000428080A Expired CA1195977A (en) | 1982-05-15 | 1983-05-13 | Quinazoline cardiac stimulants |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4489075A (forum.php) |
| EP (1) | EP0094766B1 (forum.php) |
| JP (1) | JPS58208289A (forum.php) |
| KR (1) | KR840004747A (forum.php) |
| AU (1) | AU538171B2 (forum.php) |
| CA (1) | CA1195977A (forum.php) |
| DD (2) | DD210269A5 (forum.php) |
| DE (1) | DE3368631D1 (forum.php) |
| DK (1) | DK210183A (forum.php) |
| ES (3) | ES8407039A1 (forum.php) |
| FI (1) | FI831684A7 (forum.php) |
| GR (1) | GR77498B (forum.php) |
| IL (1) | IL68668A0 (forum.php) |
| IN (1) | IN160680B (forum.php) |
| NO (1) | NO831728L (forum.php) |
| NZ (1) | NZ204225A (forum.php) |
| PH (1) | PH18763A (forum.php) |
| PL (2) | PL241968A1 (forum.php) |
| PT (1) | PT76687B (forum.php) |
| SU (1) | SU1194257A3 (forum.php) |
| YU (1) | YU105083A (forum.php) |
| ZA (1) | ZA833422B (forum.php) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138062A (en) * | 1989-10-03 | 1992-08-11 | Philip Morris Incorporated | Nicotine analogs |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| CZ289756B6 (cs) * | 1991-03-28 | 2002-04-17 | Eisai Co., Ltd. | Heterocyklicko-cyklické aminové deriváty, meziprodukty postupu přípravy těchto sloučenin, farmaceutický prostředek a pouľití uvedených derivátů |
| PL3143019T3 (pl) * | 2014-05-15 | 2021-03-22 | Pfizer Inc. | Krystaliczna postać 6-[(4R)-4-metylo-1,2-dioksydo-1,2,6-tiadiazynan-2-ylo]izochinolino-1-karbonitrylu |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971783A (en) * | 1973-03-07 | 1976-07-27 | Pfizer Inc. | 4-Aminoquinazoline derivatives as cardiac stimulants |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US4171363A (en) * | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
-
1983
- 1983-04-27 US US06/489,271 patent/US4489075A/en not_active Expired - Fee Related
- 1983-05-05 EP EP83302529A patent/EP0094766B1/en not_active Expired
- 1983-05-05 DE DE8383302529T patent/DE3368631D1/de not_active Expired
- 1983-05-10 IN IN297/DEL/83A patent/IN160680B/en unknown
- 1983-05-11 ES ES522278A patent/ES8407039A1/es not_active Expired
- 1983-05-11 DK DK210183A patent/DK210183A/da not_active Application Discontinuation
- 1983-05-12 IL IL68668A patent/IL68668A0/xx unknown
- 1983-05-12 YU YU01050/83A patent/YU105083A/xx unknown
- 1983-05-13 SU SU833597905A patent/SU1194257A3/ru active
- 1983-05-13 PT PT76687A patent/PT76687B/pt unknown
- 1983-05-13 PL PL24196883A patent/PL241968A1/xx unknown
- 1983-05-13 CA CA000428080A patent/CA1195977A/en not_active Expired
- 1983-05-13 FI FI831684A patent/FI831684A7/fi not_active Application Discontinuation
- 1983-05-13 PH PH28901A patent/PH18763A/en unknown
- 1983-05-13 NO NO831728A patent/NO831728L/no unknown
- 1983-05-13 ZA ZA833422A patent/ZA833422B/xx unknown
- 1983-05-13 AU AU14522/83A patent/AU538171B2/en not_active Ceased
- 1983-05-13 GR GR71346A patent/GR77498B/el unknown
- 1983-05-13 NZ NZ204225A patent/NZ204225A/en unknown
- 1983-05-13 DD DD83250918A patent/DD210269A5/de unknown
- 1983-05-13 DD DD83259680A patent/DD216018A5/de unknown
- 1983-05-13 PL PL24705483A patent/PL247054A1/xx unknown
- 1983-05-14 KR KR1019830002145A patent/KR840004747A/ko not_active Withdrawn
- 1983-05-16 JP JP58085660A patent/JPS58208289A/ja active Pending
- 1983-12-28 ES ES528482A patent/ES8504794A1/es not_active Expired
- 1983-12-28 ES ES528481A patent/ES8504793A1/es not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138062A (en) * | 1989-10-03 | 1992-08-11 | Philip Morris Incorporated | Nicotine analogs |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA833422B (en) | 1984-02-29 |
| EP0094766A2 (en) | 1983-11-23 |
| DD210269A5 (de) | 1984-06-06 |
| US4489075A (en) | 1984-12-18 |
| YU105083A (en) | 1986-02-28 |
| ES522278A0 (es) | 1984-08-16 |
| AU538171B2 (en) | 1984-08-02 |
| PH18763A (en) | 1985-09-20 |
| PL247054A1 (en) | 1985-03-26 |
| ES528481A0 (es) | 1985-05-01 |
| IN160680B (forum.php) | 1987-07-25 |
| EP0094766B1 (en) | 1986-12-30 |
| SU1194257A3 (ru) | 1985-11-23 |
| FI831684L (fi) | 1983-11-16 |
| ES8504793A1 (es) | 1985-05-01 |
| ES8407039A1 (es) | 1984-08-16 |
| GR77498B (forum.php) | 1984-09-24 |
| FI831684A0 (fi) | 1983-05-13 |
| IL68668A0 (en) | 1983-09-30 |
| DE3368631D1 (de) | 1987-02-05 |
| JPS58208289A (ja) | 1983-12-03 |
| KR840004747A (ko) | 1984-10-24 |
| DK210183A (da) | 1983-11-16 |
| FI831684A7 (fi) | 1983-11-16 |
| NO831728L (no) | 1983-11-16 |
| DD216018A5 (de) | 1984-11-28 |
| AU1452283A (en) | 1983-11-17 |
| PT76687A (en) | 1983-06-01 |
| ES528482A0 (es) | 1985-05-01 |
| PT76687B (en) | 1986-03-27 |
| PL241968A1 (en) | 1984-08-13 |
| NZ204225A (en) | 1985-12-13 |
| EP0094766A3 (en) | 1984-12-12 |
| DK210183D0 (da) | 1983-05-11 |
| ES8504794A1 (es) | 1985-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7951821B2 (en) | N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy | |
| CA1340192C (en) | Cyclic amine compound | |
| US4001422A (en) | 4-aminoquinazoline cardiac stimulants | |
| CA2007553A1 (en) | Cyclic amine compounds and their production | |
| US4670449A (en) | Dihydropyridines | |
| EP0279681A2 (en) | Saturated heterocyclic carboxamide derivatives | |
| US4188391A (en) | 4-[4-(Substituted)piperidino]quinazoline cardiac stimulants | |
| KR900001204B1 (ko) | 1-[(아미노알킬 및 아미노알킬아미노)카보닐 및 티오카보닐]-α, α-디아릴피롤리딘, 피페리딘 및 호모피페리딘 아세트아미드 및 아세토니트릴의 제조방법 | |
| JPH05148228A (ja) | 新規１，４−二置換ピペリジン、その製法と治療用途 | |
| IE55904B1 (en) | Dihydropyridines | |
| JPH0351708B2 (forum.php) | ||
| US4292321A (en) | 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof | |
| KR870000905B1 (ko) | 퀴나졸린 화합물의 제조방법 | |
| US7659402B2 (en) | Piperidines as opioid receptor modulators | |
| CA1195977A (en) | Quinazoline cardiac stimulants | |
| SK33099A3 (en) | Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase | |
| US4540780A (en) | Diphenylmethylene piperidines | |
| CA2205837A1 (en) | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof | |
| US4783467A (en) | Tetrahydroimidazoquinazolinone inotropic agents | |
| US4666905A (en) | Diphenylmethylene piperidines compositions and methods for their use | |
| US4411904A (en) | Diphenylpropanamines, compositions thereof and use thereof | |
| EP0150939A1 (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
| EP0294183B1 (en) | Use of ethylamine derivatives as antihypertensive agents | |
| US4778802A (en) | Heterocyclic compounds | |
| US4364954A (en) | Diphenylpropanamines, compositions thereof and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEC | Expiry (correction) | ||
| MKEX | Expiry |